Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01815957 · ClinicalTrials.gov registry record · NA
Impact of Ranolazine on Coronary Microcirculatory Resistance
A NA study, sponsored by University of New Mexico.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01815957: Completed NA study, sponsored by University of New Mexico.
NCT01815957 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01815957, a NA study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study is being done to determine if Ranolazine treatment improves coronary microcirculation function among patients with coronary microcirculation dysfunction. We are also looking to learn if symptomatic improvement of chest pain during treatment with Ranalozine is related to improved coronary microcirculation function.
Interventions
- DRUG Rnalozine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2012-05 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT01815957 record still lists
NCT01815957 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Rnalozine is the first listed.
NCT01815957 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01815957 about?
NCT01815957 is a clinical study titled "Impact of Ranolazine on Coronary Microcirculatory Resistance". This study is being done to determine if Ranolazine treatment improves coronary microcirculation function among patients with coronary microcirculation dysfunction. We are also looking to learn if symptomatic improvement of chest pain during treatment with Ranalozine is related to improved coronary ...
What is the current status of trial NCT01815957?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2012-05. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01815957?
The interventions under investigation include: Rnalozine (DRUG).
Who is sponsoring clinical trial NCT01815957?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01815957's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia